REVIEW
|
doi:10.20944/preprints202308.1044.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
colorectal cancer; second-line treatment; angiogenesis inhibitor; VEGF-A; VEGF-D
Online: 15 August 2023 (02:47:40 CEST)